Hepatology
Conference Coverage
Home-based system relieves refractory ascites in cirrhosis
A tunneled peritoneal catheter drainage system relieved symptoms with an infection risk similar to standard of care.
Conference Coverage
Liver cancer risk lingers even after HCV eradication
Not having a sustained viral response was associated with a more than sevenfold higher risk for liver cancer in a multicenter study.
Conference Coverage
Bulevirtide shows real-world efficacy versus HDV
French program reveals good cure rates, but also a high rate of modifications or discontinuations.
Conference Coverage
NAFLD, ALD prevalent among teens, young adults
It’s important to “mitigate modifiable risk factors to prevent disease development and disease progression to potentially advanced fibrosis and...
Conference Coverage
Patient risk, not disease duration, key to timing biologics in IBD
The proportional biologic/placebo treatment effect on remission and response to biologics was not influenced by disease duration in UC or CD...
Conference Coverage
Be cautious with HBV drug withdrawal
Severe flares can follow in the long term after withdrawal of nucleoside/nucleotide analogues.
Conference Coverage
In pill or food form, healthy fatty acids reduce liver fat
For patients with NAFLD who supplement their diets with polyunsaturated fatty acids, liver and metabolic parameters improve, results of a...
Conference Coverage
Cirrhosis comorbidities tied to worse outcomes
Compensated cirrhosis patients with three comorbidities may be as bad off as decompensated patients with none.
From the Journals
Human CRP protects against acetaminophen-induced liver injury in mice
NAC is effective during only the early phases of the acetaminophen-induced liver injury, whereas human CRP was still highly effective in this...
From the Journals
AGA Clinical Care Pathway: Screening, diagnosis, and treatment of NAFLD and NASH
The authors recommended a four-step screening process for NAFLD/NASH based on available literature and clinical experience.
Conference Coverage
Alcohol-related liver disease severity increased during COVID-19 pandemic
Increased alcohol sales and disrupted services may have led to worse clinical outcomes.